Phytonadione NDC 76282-740

NDC codes

FDA NDC Directory

Product NDC (as listed)76282-740Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76282-0740Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76282-740-30	76282074030	1 BOTTLE in 1 CARTON (76282-740-30) / 30 TABLET in 1 BOTTLEMarketed from Dec 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phytonadione
Generic name (nonproprietary): phytonadione
Active ingredients: Phytonadione — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Exelan Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213329
Marketing start: Dec 1, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Increased Prothrombin Activity (Physiologic effect)Reversed Anticoagulation Activity (Physiologic effect)Vitamin K (Chemical structure)
Identifiers: Product ID 76282-740_1c09ec9b-5913-42d4-92e2-34d26682556aSPL ID 1c09ec9b-5913-42d4-92e2-34d26682556aSPL set ID 63771c95-d4f5-42eb-b591-4df146f18cb0RxCUI 198102UNII A034SE7857UPC 0376282740300
Pharmacologic class: Vitamin K; Warfarin Reversal Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476282074030 followed by a unit qualifier and the quantity

Package 76282-0740-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 1, 2023.

Indications (excerpt from the label)

Phytonadione is indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. Phytonadione is indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. • anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; • hypoprothrombinemia secondary to antibacterial therapy; • hypoprothrombinemia secondary to factors limiting absorpsion or synthesis of vi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213329

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213329
Product	Strength	Form · route	Labeler	Product NDC
Phytonadione	Phytonadione 5 mg/1	TabletOral	Cipla USA., Inc.	69097-999
Phytonadione	Phytonadione 5 mg/1	TabletOral	ScieGen Pharmaceuticals Inc	50228-333